Cargando…
Novel use of XSTAT 30 for mitigation of lethal non-compressible torso hemorrhage in swine
BACKGROUND: Management of Non-Compressible Torso Hemorrhage (NCTH) consists primarily of aortic occlusion which has significant adverse outcomes, including ischemia-reperfusion injury, in prolonged field care paradigms. One promising avenue for treatment is through use of RevMedx XSTAT 30™ (an FDA a...
Autores principales: | Bonanno, Alicia M., Graham, Todd L., Wilson, Lauren N., Ross, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673511/ https://www.ncbi.nlm.nih.gov/pubmed/33206692 http://dx.doi.org/10.1371/journal.pone.0241906 |
Ejemplares similares
-
Management of non-compressible torso hemorrhage: An update
por: Zhang, Zhi-Yang, et al.
Publicado: (2021) -
A novel tamponade agent for management of post partum hemorrhage: adaptation of the Xstat mini-sponge applicator for obstetric use
por: Rodriguez, Maria I., et al.
Publicado: (2017) -
Torso damage control for ongoing hemorrhage: Tips and tricks
por: Kaminsky, Matt
Publicado: (2021) -
Thermoreversible Reverse-Phase-Shift Foam for Treatment of Noncompressible Torso Hemorrhage, a Safety Trial in a Porcine Model
por: Donaldson, Ross I, et al.
Publicado: (2022) -
Partial Versus Complete Resuscitative Endovascular Balloon Occlusion of the Aorta in Exsanguinating Trauma Patients With Non-Compressible Torso Hemorrhage
por: Heindl, Stacey E, et al.
Publicado: (2020)